KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Accuray (ARAY) EBITDA (2016 - 2025)

Historic EBITDA for Accuray (ARAY) over the last 16 years, with Q4 2025 value amounting to -$13.2 million.

  • Accuray's EBITDA fell 335078.53% to -$13.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$30.5 million, marking a year-over-year decrease of 33204.31%. This contributed to the annual value of $794000.0 for FY2025, which is 10393.28% up from last year.
  • As of Q4 2025, Accuray's EBITDA stood at -$13.2 million, which was down 335078.53% from -$21.8 million recorded in Q3 2025.
  • Over the past 5 years, Accuray's EBITDA peaked at $5.8 million during Q2 2023, and registered a low of -$21.8 million during Q3 2025.
  • Moreover, its 5-year median value for EBITDA was -$925000.0 (2021), whereas its average is -$2.4 million.
  • As far as peak fluctuations go, Accuray's EBITDA skyrocketed by 153636.36% in 2021, and later tumbled by 335078.53% in 2025.
  • Over the past 5 years, Accuray's EBITDA (Quarter) stood at $71000.0 in 2021, then skyrocketed by 1190.14% to $916000.0 in 2022, then tumbled by 847.6% to -$6.8 million in 2023, then surged by 94.42% to -$382000.0 in 2024, then plummeted by 3350.79% to -$13.2 million in 2025.
  • Its last three reported values are -$13.2 million in Q4 2025, -$21.8 million for Q3 2025, and $5.6 million during Q2 2025.